The aim of this study was to evaluate tumor proliferation and the expression of the oncogenes HER2/neu, BCL2 and tumor suppressor gene p53 in patients undergoing pros-tatectomy for localized prostate carcinoma, and to define their prognostic roles through correlation with final Gleason score, tumor stage and tumor volume. This evidence concerns the gene ERBB2 and neoplasm.